Walleye Trading’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

Walleye Trading’s Portfolio PEARW Stock Details PEARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10,643	Closed	-$203	–	5487
2023 Q1	$203	Hold	10,643	–	–	﹤0.01%	4766
2022 Q4	$1.58K	Hold	10,643	–	–	﹤0.01%	4764
2022 Q3	$2K	Hold	10,643	–	–	﹤0.01%	4840
2022 Q2	$1K	Hold	10,643	–	–	﹤0.01%	5021
2022 Q1	$8K	Hold	10,643	–	–	﹤0.01%	5023
2021 Q4	$6K	Sell	10,643 -2,690	-20%	-$2.73K	﹤0.01%	5195
2021 Q3	$13K	Hold	13,333	–	–	﹤0.01%	4965
2021 Q2	$20K	Buy	+13,333	New	+$11.6K	﹤0.01%	4850

Other funds holding PEARW

Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Walleye Trading's PEARW Position: Q2 2023 in Review

Walleye Trading sold out of Pear Therapeutics, Inc. Warrant (PEARW) in Q2 2023, closing a stake of 10,643 shares — an estimated $203 sold.

Walleye Trading first reported a position in PEARW in Q2 2021 and held it in 8 quarters. The position peaked at $20K in Q2 2021. 2 funds tracked by Wall St. Rank hold PEARW as of Q2 2023.

Walleye Trading reported no remaining Pear Therapeutics, Inc. Warrant position as of Q2 2023 after selling out during the quarter.
Walleye Trading sold 10,643 Pear Therapeutics, Inc. Warrant shares in Q2 2023, an estimated $203.
Walleye Trading first reported a position in Pear Therapeutics, Inc. Warrant in Q2 2021 and held it in 8 quarters.
Walleye Trading's Pear Therapeutics, Inc. Warrant position peaked at $20K in Q2 2021.
2 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Warrant as of Q2 2023.

Based on Walleye Trading's 13F filing for Q2 2023, filed 14 Aug 2023.